Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.

Elwir S, Rahimi RS.

J Clin Transl Hepatol. 2017 Jun 28;5(2):142-151. doi: 10.14218/JCTH.2016.00069. Epub 2017 May 4. Review.

2.

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med. 2017 Oct;45(10):1616-1624. doi: 10.1097/CCM.0000000000002562.

3.

Role of albumin in cirrhosis: from a hospitalist's perspective.

Walayat S, Martin D, Patel J, Ahmed U, N Asghar M, Pai AU, Dhillon S.

J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):8-14. doi: 10.1080/20009666.2017.1302704. eCollection 2017 Jan. Review.

4.

Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Bellomo R, Ronco C, Mehta RL, Asfar P, Boisramé-Helms J, Darmon M, Diehl JL, Duranteau J, Hoste EAJ, Olivier JB, Legrand M, Lerolle N, Malbrain MLNG, Mårtensson J, Oudemans-van Straaten HM, Parienti JJ, Payen D, Perinel S, Peters E, Pickkers P, Rondeau E, Schetz M, Vinsonneau C, Wendon J, Zhang L, Laterre PF.

Ann Intensive Care. 2017 Dec;7(1):49. doi: 10.1186/s13613-017-0260-y. Epub 2017 May 4. Review.

5.

Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Wilms C, Hüsing-Kabar A, Görlich D, Kabar I, Schmidt HH.

PLoS One. 2017 Apr 12;12(4):e0175529. doi: 10.1371/journal.pone.0175529. eCollection 2017.

6.

First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.

Huber W, Henschel B, Schmid R, Al-Chalabi A.

BMC Gastroenterol. 2017 Feb 16;17(1):32. doi: 10.1186/s12876-017-0569-x.

7.

Acute-on-chronic liver failure: an update.

Hernaez R, Solà E, Moreau R, Ginès P.

Gut. 2017 Mar;66(3):541-553. doi: 10.1136/gutjnl-2016-312670. Epub 2017 Jan 4. Review.

8.

Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis.

Qin G, Bian ZL, Shen Y, Zhang L, Zhu XH, Liu YM, Shao JG.

BMC Med Inform Decis Mak. 2016 Jun 4;16:59. doi: 10.1186/s12911-016-0302-7.

9.

Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis.

Shen Y, Wang XL, Wang B, Shao JG, Liu YM, Qin Y, Wang LJ, Qin G.

Medicine (Baltimore). 2016 Jan;95(3):e2506. doi: 10.1097/MD.0000000000002506. Review.

10.

Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure.

He GL, Feng L, Duan CY, Hu X, Zhou CJ, Cheng Y, Pan MX, Gao Y.

Int J Clin Exp Med. 2015 Oct 15;8(10):17046-54. eCollection 2015. Review.

11.

Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.

Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D, Bauschke A, Settmacher U, Kohl M, Clemens MG, Mitzner S, Bauer M, Kortgen A.

Crit Care. 2016 Jan 4;20:2. doi: 10.1186/s13054-015-1159-3.

12.

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.

Shawcross DL, Dunk AA, Jalan R, Kircheis G, de Knegt RJ, Laleman W, Ramage JK, Wedemeyer H, Morgan IE; New Insights Steering Committee.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):146-52. doi: 10.1097/MEG.0000000000000529. Review.

13.

Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Luo M, Guo JY, Cao WK.

World J Gastroenterol. 2015 Nov 7;21(41):11815-24. doi: 10.3748/wjg.v21.i41.11815. Review.

14.

Covert and Overt Hepatic Encephalopathy: Diagnosis and Management.

Patidar KR, Bajaj JS.

Clin Gastroenterol Hepatol. 2015 Nov;13(12):2048-61. doi: 10.1016/j.cgh.2015.06.039. Epub 2015 Jul 9. Review.

15.

Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Aldridge DR, Tranah EJ, Shawcross DL.

J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S7-S20. doi: 10.1016/j.jceh.2014.06.004. Epub 2014 Jun 30. Review.

16.

Management of hepatorenal syndrome.

Dundar HZ, Yılmazlar T.

World J Nephrol. 2015 May 6;4(2):277-86. doi: 10.5527/wjn.v4.i2.277. Review.

17.

Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation.

Olin P, Hausken J, Foss A, Karlsen TH, Melum E, Haugaa H.

Scand J Gastroenterol. 2015;50(9):1127-34. doi: 10.3109/00365521.2015.1027262. Epub 2015 Apr 11.

18.

Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Kim W, Kim DJ.

World J Hepatol. 2014 Oct 27;6(10):688-95. doi: 10.4254/wjh.v6.i10.688. Review.

19.

Management of hepatic encephalopathy in the hospital.

Leise MD, Poterucha JJ, Kamath PS, Kim WR.

Mayo Clin Proc. 2014 Feb;89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8. Review.

20.

Supplemental Content

Support Center